BIOMAT Database Logo BIOMAT Database Logo

[Granulocyte transfusion in hematological disorders methods and clinical effects (author's transl)]. 1977

I Kurokawa, and Y Moriyama

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D005260 Female Females
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

I Kurokawa, and Y Moriyama
[Clinical results with granulocyte transfusion (author's transl)].
May 1979, Medizinische Klinik,
I Kurokawa, and Y Moriyama
[Granulocyte transfusion (author's transl)].
December 1980, Revista medica de Chile,
I Kurokawa, and Y Moriyama
[Platelet and granulocyte transfusion and HLA (author's transl)].
October 1978, Rinsho byori. The Japanese journal of clinical pathology,
I Kurokawa, and Y Moriyama
Granulocyte dysfunction in hematological disorders.
January 1992, Cancer investigation,
I Kurokawa, and Y Moriyama
[Granulocyte transfusion by continuous flow filtration leukapheresis (CFFL) (author's transl)].
September 1978, [Rinsho ketsueki] The Japanese journal of clinical hematology,
I Kurokawa, and Y Moriyama
[Ultrastructure of erythroblasts in various hematological disorders (author's transl)].
July 1974, [Rinsho ketsueki] The Japanese journal of clinical hematology,
I Kurokawa, and Y Moriyama
[Transfusion and its adverse effects in patients with hematological disorders].
February 2002, [Rinsho ketsueki] The Japanese journal of clinical hematology,
I Kurokawa, and Y Moriyama
[Chronic renal failure and hematological disorders, particularly anemia (author's transl)].
February 1974, [Rinsho ketsueki] The Japanese journal of clinical hematology,
I Kurokawa, and Y Moriyama
[Indications and clinical aspects of granulocyte transfusions (author's transl)].
December 1981, Deutsche medizinische Wochenschrift (1946),
I Kurokawa, and Y Moriyama
[Clinical and experimental studies on aldolase and its isoenzymes in leukemia and allied hematological disorders (author's transl)].
September 1979, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
Copied contents to your clipboard!